Three cases of difficulty in achieving definitive loss of consciousness with remimazolam

BACKGROUND: Remimazolam is a novel, ultra-short-acting benzodiazepine used for general anesthesia. Because remimazolam is an emerging drug, the tolerance to remimazolam in benzodiazepine-taking patients has been unclear. Also, the efficacy of remimazolam in different races is not fully elucidated so...

Descripción completa

Detalles Bibliográficos
Autores principales: Miyanishi, Mao, Yaguramaki, Toru, Maehara, Yasuhiro, Nagata, Osamu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8752651/
https://www.ncbi.nlm.nih.gov/pubmed/35015166
http://dx.doi.org/10.1186/s40981-021-00485-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8752651/
https://www.ncbi.nlm.nih.gov/pubmed/35015166
http://dx.doi.org/10.1186/s40981-021-00485-1

Ejemplares similares